T1	Entity 0 5	BRCA2
T3	SNP 149 159	rs11571833
T4	SNP 137 147	p.Lys3326*
T5	SNP 126 135	c.9976A>T
T6	Association 44 48	Risk
E1	Association:T6 bc:T7 snp_int:T8
T7	Cancer 52 58;82 88	Breast Cancer
T2	Entity 29 35	K3326X
T8	SNP 0 35	BRCA2 Polymorphic Stop Codon K3326X
R1	SNP_coupled_gene Arg1:T8 Arg2:T1	
R2	SNP_allele Arg1:T8 Arg2:T2	
T9	Entity 95 101	K3326X
T10	Entity 120 125	BRCA2
R3	SNP_coupled_gene Arg1:T5 Arg2:T10	
R4	SNP_allele Arg1:T5 Arg2:T9	
R5	Equiv Arg1:T5 Arg2:T4	
R6	Equiv Arg1:T4 Arg2:T3	
T11	Association 214 219	risks
E2	Association:T11 bc:T14 snp_int:T3
T12	Level 198 203	small
T13	Effect_Type 204 213	increased
R7	Effect_type_marker Arg1:E2 Arg2:T13	
R8	Level_marker Arg1:E2 Arg2:T12	
T14	Cancer 223 236	breast cancer
A1	Effect_Type E2 Increase
A2	Level E2 Low
T15	Spec 378 395	scant information
T16	Other_effect 406 412	effect
E3	Other_effect:T16 Agent:T17 Theme:T19
T17	SNP 416 422	K3326X
T18	Entity 416 422	K3326X
R9	SNP_allele Arg1:T17 Arg2:T18	
R10	Speculation_marker Arg1:E3 Arg2:T15	
T19	Entity 432 455	hormone-related cancers
T20	SNP 95 109	K3326X variant
R11	Equiv Arg1:T20 Arg2:T5	
R12	Equiv Arg1:T17 Arg2:T20	
T21	Spec 606 614	estimate
T22	SNP 672 686	K3326X variant
T23	Association 699 707	relation
E4	Association:T23 bc:T24 snp_int:T22
R13	Speculation_marker Arg1:E4 Arg2:T21	
T24	Cancer 711 717;741 747	breast cancer
T25	Spec 882 890	examined
T26	Association 895 907	associations
E5	Association:T26 snp_int:T27 bc:T28
T27	SNP 911 917	K3326X
R14	Equiv Arg1:T27 Arg2:T17	
R15	Speculation_marker Arg1:E5 Arg2:T25	
T28	Cancer 923 929;942 948	breast cancer
T29	Entity 966 988	BRCA1 variant carriers
R16	Risk_Factor Arg1:T27 Arg2:T29	
T30	SNP 1032 1046	K3326X variant
T31	Entity 1032 1038	K3326X
R17	SNP_allele Arg1:T30 Arg2:T31	
T32	Association 1051 1061	associated
E6	Association:T32 bc:T33 snp_int:T30
T33	Cancer 1067 1073;1150 1156	breast cancer
T34	Level 1234 1242	stronger
T35	Association 1216 1228	associations
E7	Association:T35 snp_int:T31 bc:T36
A3	Level E7 High
R18	Level_marker Arg1:E7 Arg2:T34	
T36	Cancer 1277 1317	estrogen receptor-negative breast cancer
A4	Cancer_Type T36 ER-
T37	Organic_inorganic_molecules_affected 1216 1228	associations
E8	Organic_inorganic_molecules_affected:T37 Agent:T30 Theme:T38
T38	Entity 1277 1294	estrogen receptor
T39	Neg 1295 1303	negative
R19	Negation_marker Arg1:E8 Arg2:T39	
T40	Entity 1442 1465	BRCA1 mutation carriers
T43	SNP 1532 1546	K3326X variant
T44	Entity 1532 1538	K3326X
R21	SNP_allele Arg1:T43 Arg2:T44	
T45	Neg 1624 1626	no
T46	Association 1627 1638	association
E10	Association:T46 snp_int:T43 bc:T47
T47	Cancer 1644 1657	breast cancer
R22	Negation_marker Arg1:E10 Arg2:T45	
R23	Risk_Factor Arg1:T43 Arg2:T40	
T52	SNP 1746 1760	K3326X variant
T53	Entity 1746 1752	K3326X
R25	SNP_allele Arg1:T52 Arg2:T53	
T54	Spec 1728 1736	evidence
T55	Association 1764 1774	associated
E12	Association:T55 bc:T56 snp_int:T52
T56	Cancer 1799 1805;1818 1825	breast cancers
T58	Neg 1826 1837	independent
T59	Entity 1841 1875	other pathogenic variants in BRCA2
R26	Negation_marker Arg1:T59 Arg2:T58	
R27	Risk_Factor Arg1:T52 Arg2:T59	
R28	Speculation_marker Arg1:E12 Arg2:T54	
T61	Organic_inorganic_molecules_affected 18 28	Stop Codon
E14	Organic_inorganic_molecules_affected:T61 Agent:T5 Theme:T62 Theme2:T64
T62	Entity 137 146	p.Lys3326
T63	Entity 133 135	>T
R30	Nucleotide_substitution Arg1:T4 Arg2:T63	
T64	Entity 29 34	K3326
T65	Entity 911 917	K3326X
R31	SNP_allele Arg1:T27 Arg2:T65	
A5	SNP_Type T20 Nonsense
A6	SNP_Type T3 Nonsense
A7	SNP_Type T17 Nonsense
A8	SNP_Type T27 Nonsense
A9	SNP_Type T43 Nonsense
A10	SNP_Type T52 Nonsense
A11	SNP_Type T30 Nonsense
A12	SNP_Type T22 Nonsense
A13	SNP_Type T8 Nonsense
